β-Methyl-2C-B

β-Methyl-2C-B
Clinical data
Other namesBMB; 4-Bromo-2,5-dimethoxy-β-methylphenethylamine
Routes of
administration		Oral[1]
Drug classPsychoactive drug
Legal status
Legal status
  • UK: In General Unscheduled
Pharmacokinetic data
Duration of action~8 hours[1]
Identifiers
  • 2-(4-bromo-2,5-dimethoxyphenyl)propan-1-amine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H16BrNO2
Molar mass274.158 g·mol−1
3D model (JSmol)
  • CC(CN)C1=CC(=C(C=C1OC)Br)OC
  • InChI=1S/C11H16BrNO2/c1-7(6-13)8-4-11(15-3)9(12)5-10(8)14-2/h4-5,7H,6,13H2,1-3H3
  • Key:YJJFYOKEGOFNFA-UHFFFAOYSA-N

β-Methyl-2C-B (BMB), also known as 4-bromo-2,5-dimethoxy-β-methylphenethylamine, is a psychoactive drug of the phenethylamine and 2C families related to the BOx drugs.[1] It is the β-methyl derivative of 2C-B and a structural isomer of DOB (α-methyl-2C-B), but is less potent than either of these drugs.[1] The drug has around half the potency of 2C-B itself, with effects occurring at a dose of around 20 mg orally and with a duration of approximately 8 hours.[1] Moreover, its effects were described as very different from those of 2C-B and effects typical of 2C-B were said to be largely absent.[1] It has two possible enantiomers but their activity has not been tested separately.[1] BMB was described by Daniel Trachsel in his 2013 book Phenethylamine: Von der Struktur zur Funktion (Phenethylamines: From Structure to Function).[1]

See also

References

  1. ^ a b c d e f g h Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: Von der Struktur zur Funktion. Nachtschatten Verlag AG. pp. 833–834. ISBN 978-3-03788-700-4.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.